Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Center for Global Development, London, UK.
BMJ Glob Health. 2024 Jun 10;9(6):e015079. doi: 10.1136/bmjgh-2024-015079.
Ayushman Bharat Pradhan Mantri Jan Aarogya Yojana (PM-JAY) is one of the world's largest tax-funded insurance schemes. The present study was conducted to understand the decision-making process around the evolution (and revision) of health benefit packages (HBPs) and reimbursement rates within PM-JAY, with a specific focus on assessing the extent of use of economic evidence and role of various stakeholders in shaping these policy decisions.
A mixed-methods study was adopted involving in-depth interviews with seven key stakeholders involved in HBP design and reimbursement rates decisions, and a survey of 80 government staff and other relevant stakeholders engaged in the implementation of PM-JAY. The data gathered were thematically analysed, and a coding framework was developed to explore specific themes. Additionally, publicly available documents were reviewed to ensure a comprehensive understanding of the decision-making processes.
Findings reveal a progressive transition towards evidence-based practices for policy decisions within PM-JAY. The initial version of HBP relied heavily on key criteria like disease burden, utilisation rates, and out-of-pocket expenditures, along with clinical opinion in shaping decisions around the inclusion of services in the HBP and setting reimbursement rates. Revised HBPs were informed based on evidence from a national-level costing study and broader stakeholder consultations. The use of health economic evidence increased with each additional revision with consideration of health technology assessment (HTA) evidence for some packages and reimbursement rates based on empirical cost evidence in the most recent update. The establishment of the Health Financing and Technology Assessment unit further signifies the use of evidence-based policymaking within PM-JAY. However, challenges persist, notably with regard to staff capacity and understanding of HTA principles, necessitating ongoing education and training initiatives.
While substantial progress has been made in transitioning towards evidence-based practices within PM-JAY, sustained efforts and political commitment are required for the ongoing systematisation of processes.
阿育王·巴拉特·普拉丹·曼特里·贾恩·阿罗格亚·约哈纳(PM-JAY)是世界上最大的税收资助保险计划之一。本研究旨在了解 PM-JAY 中健康福利套餐(HBPs)和报销率的演变(和修订)决策过程,特别关注评估经济证据的使用程度以及各种利益相关者在制定这些政策决策中的作用。
采用混合方法研究,对参与 HBP 设计和报销率决策的七名关键利益相关者进行深入访谈,并对参与 PM-JAY 实施的 80 名政府工作人员和其他相关利益相关者进行调查。对收集的数据进行主题分析,并制定编码框架以探索具体主题。此外,还审查了公开文件,以确保全面了解决策过程。
研究结果表明,PM-JAY 中的政策决策逐渐向基于证据的实践转变。最初的 HBP 版本主要依赖于疾病负担、利用率和自付支出等关键标准,以及临床意见,以确定将服务纳入 HBP 和设定报销率的决策。修订后的 HBP 是根据国家层面的成本研究和更广泛的利益相关者协商的证据得出的。随着每次修订,对健康技术评估(HTA)证据的考虑以及对最近更新中一些套餐和报销率的实证成本证据的考虑,经济证据的使用增加了。卫生融资和技术评估股的设立进一步标志着 PM-JAY 内部基于证据的决策制定的使用。然而,仍然存在挑战,特别是在员工能力和对 HTA 原则的理解方面,需要持续开展教育和培训计划。
虽然在向 PM-JAY 中的基于证据的实践转变方面取得了重大进展,但需要持续努力和政治承诺,以实现过程的持续系统化。